PMID: 9449275Feb 4, 1998Paper

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

Antimicrobial Agents and Chemotherapy
J R GraybillS L Regen

Abstract

KY-62 is a water-soluble analog of amphotericin B. In vitro testing of five clinical isolates of Candida albicans showed KY-62 to have potency similar to that of amphotericin B. KY-62 was administered to mice infected intravenously with C. albicans. In vivo, KY-62 was effective in immunocompetent mice, with potency similar to that of amphotericin B. KY-62 was well tolerated up to 30 mg/kg of body weight per dose, an amount that would be lethal with amphotericin B. KY-62 was less effective in mice rendered neutropenic with 5-fluorouracil. The addition of flucytosine had little effect. KY-62 may have potential for clinical development.

References

Nov 1, 1978·Antimicrobial Agents and Chemotherapy·J R GraybillD J Drutz
Oct 1, 1992·Clinical Pharmacokinetics·R JanknegtD J Crommelin
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P D Hoeprich
May 1, 1991·Antimicrobial Agents and Chemotherapy·E WilsonD P Speert
Feb 1, 1990·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff
Jul 1, 1990·Antimicrobial Agents and Chemotherapy·S P RacisC P Schaffner
Jun 1, 1989·European Journal of Epidemiology·T J Walsh, D M Dixon
Aug 1, 1982·The Journal of Infectious Diseases·W G EllisS L Nielsen
Aug 1, 1982·The Journal of Infectious Diseases·P Hoeprich
Oct 1, 1994·Antimicrobial Agents and Chemotherapy·A Vertut-DoïJ Bolard
May 1, 1994·The Journal of Antimicrobial Chemotherapy·S de MarieI A Bakker-Woudenberg
Nov 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H J Schmitt
Aug 1, 1996·Antimicrobial Agents and Chemotherapy·M TohyamaA Saito

❮ Previous
Next ❯

Citations

May 25, 2005·Chemistry & Biology·Elena M SecoFrancisco Malpartida
Sep 22, 2007·Animal Reproduction Science·K Dvoráková-HortováJ Peknicová

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.